Market Reports

CHINA DERMATOSIS DRUG MARKET REPORT

106 Pages | 2009 Analysis

Publisher: Draco
Distributor: Medtech Insight / LSI

Dermatosis diseases are common diseases in China with high incidence and recurrence rates. The dermatosis disease rate is about 1.23%, meaning that there are about 160 million Chinese dermatosis patients. Dermatosis drugs are ranked as the No. 3 best selling drug category (by retail sales volume) in China. There are more than 600 dermatosis drugs for external use in the Chinese drug retail market. The market size of the Chinese dermatosis drug market in 2007 is about USD $1.39 billion with a same period growth of 16.73%.

This report has systemically analyzed the Chinese dermatosis drug market. All market estimates of drug utilization in China are based on hospital drug prescription and drug purchasing data from the hospital data monitor system that the China Nan Fang Institute has developed and maintained (Nan Fang Institute is a direct subsidiary of the Chinese State Food and Drug Administration, the SFDA). Sampled hospitals are from major Chinese cities across different geographic locations, including Beijing, Shanghai, Guangzhou, Nanjing, Chengdu, Chongqing, Xian, Shenyang, Harbin and Zhengzhou, covering significant percentages of all hospital beds in these regions.

This China Dermatosis Drug Market Report has been a must have reference for decision makers in pharmaceutical companies, medical device companies, healthcare investing companies and healthcare consulting companies. These unique drug prescription and utilization data can provide valuable information for new product development, marketing and strategic planning functions for pharmaceutical companies.

THE TOP 20 PHARMACEUTICAL COMPANIES IN THE CHINESE DERMATOSIS DRUG MARKET 2007
(AT LEAST >1.17% OF THE CHINA DERMATOSIS DRUG MARKET SHARES)

Methodology for the Annual China Drug Market Reports
Key Drug Data For Each of These 18 Therapeutic Areas in China

List of Annual China Drug Market Reports 2008

Prologue

Chapter I: Summary of Dermatosis Drugs

Section 1: Current Clinical Utilization of Dermatosis Drugs in China
1. Major Anti-fungus Dermatosis Drugs
2. Major Types of Cortical Hormone Dermatosis Drugs
3. Major Dermatosis Drugs for Infectious Dermatosis and Major Disinfectants
4. Major Dermatosis Drugs for Psoriasis Treatment

Section 2: Classifications of Dermatosis drugs
1. Systemic Drug
2. External Treatment of Dermatosis Diseases
3. Physical Therapy for Dermatosis Diseases

Chapter II: Summary of The Dermatosis Drug Market

Section 1: Global Market of Dermatosis Drugs
1. Forecast of the Allergic Dermatitis Market
2. Forecast of the US Psoriasis Drug Market
3. Global Market for Burn Treatment Drugs surpassed USD 1.5 billion

Section 2: The Chinese Market of Dermatosis Drugs
Section 3: Market Shares of Dermatosis Drug categories in China
Section 4: Market Shares of the Top 20 Dermatosis Drugs in China 2005-2007
Section 5: Market Shares of the Top 20 Manufacturers in the Chinese Dermatosis Drug Market 2005-2007
Section 6: Growth Rates of the Top 20 Dermatosis Drugs 2006-2007
Section 7: Market Potentials of Key Dermatosis Drugs in China

Chapter III: Market Sizes and Growths of Key Dermatosis Drugs in China

Section 1: Top 5 Dermatosis Drugs in Each Category (11 categories)

Section 2: Top 10 Best Selling Brand Dermatosis Drugs 2006-2007
1. Market Shares, Market Sizes and Manufacturers of Terbinafine
2. Market Shares, Market Sizes and Manufacturers of Mometasone
3. Market Shares, Market Sizes and Manufacturers of Povidone Iodide
4. Market Shares, Market Sizes and Manufacturers of Econazole
5. Market Shares, Market Sizes and Manufacturers of Halometasone (Halometasone/Triclosan)
6. Market Shares, Market Sizes and Manufacturers of Hydrocortisone Butyrate
7. Market Shares, Market Sizes and Manufacturers of Miconazole Nitrate
8. Market Shares, Market Sizes and Manufacturers of Mupirocin
9. Market Shares, Market Sizes and Manufacturers of Viaminate (Viaminate/vitaminE)
10. Market Shares, Market Sizes and Manufacturers of Calcipotriol

Chapter IV: List of Brand Names, Generic Names, Formula & Manufacturers of Dermatosis Drugs in China

Chapter V: Dermatosis Drugs on the National Healthcare Insurance Coverage List

Section 1: Dermatosis Drugs on the National Basic Healthcare Insuracne List
1. Chemical Dermatosis Drugs on the National Basic Healthcare Insurance List
2. Traditional Chinese Medicine (TCM) Dermatosis Drugs on the National Basic Healthcare Insurance List

Chapter VI: R & D of Dermatosis Drugs

Section 1: New Dermatosis Drugs Approved in 2007

Section 2: New Dermatosis Drugs under Development
1. Ustekinumab
2. Enbrel

Section 3: Advancement of Dermatology Study in China
1. Transition from the Traditional Dermatology to Modern Dermatology
2. The Invention of Local Immunomodulator
3. Biologics for Psoriasis Treatment
4. Photo-therapy - Ultraviolet Radiation
5. Genetic Mutation Studies on the Genetic Dermatosis Diseases
6. Breakthrough in the Understanding of the Disease Development Mechanism of Paraneoplastic Pemphigus
7. Development of Photo Sensitizer
8. Anti-fungal Drugs
9. Laser Cosmetic Technology

Table 1: Common Corticosteroid Drugs and Dosages
Table 2: Common Antihistamine Drugs (H2 Receptor Antagonist)
Table 3: Common Corticosteroid Drugs and Dosages
Table 4: Market Shares of Dermatosis Drugs by Category 2002-2007
Table 5: Market Shares of Key Dermatosis Drugs in China 2005-2007
Table 6: Market Shares of the Top 20 Manufacturers in the Chinese Dermatosis Drug Market 2005-2007
Table 7: Market Share Growths of Key Dermatosis Drugs 2005-2007
Table 8: Top 5 Dermatosis Drugs by Category (By Sales Revenue) in 2006
Table 9: Top 5 Dermatosis Drugs by Category (By Sales Revenue) in 2007
Table 10: Market Shares and Manufacturers of Terbinafine 2005-2007
Table 11: Market Sizes and Manufacturers of Terbinafine 2006-2007
Table 12: Market Shares and Manufacturers of Mometasone 2005-2007
Table 13: Market Sizes and Manufacturers of Mometasone 2006-2007
Table 14: Market Shares and Manufacturers of Povidone Iodide 2005-2007
Table 15: Market Sizes and Manufacturers of Povidone Iodide 2006-2007
Table 16: Market Shares and Manufacturers of Econazole 2005-2007
Table 17: Market Sizes and Manufacturers of Econazole 2006-2007
Table 18: Market Shares and Manufacturers of Halometasone and Its Compound Preparations 2005-2007
Table 19: Market Sizes and Manufacturers
Table 20: Market Shares and Manufacturers of Miconazole Nitrate 2005-2007
Table 21: Market Sizes and Manufacturers of Miconazole Nitrate 2006-2007
Table 22: Market Sizes and Manufacturers of Viaminate 2005-2007
Table 23: Market Sizes and Manufacturers of Viaminate 2006-2007
Table 24: Brand Names, Generic Names, Formulas and Manufacturers of Dermatosis Drugs in China
Table 25: Chemical Dermatosis Drugs on the National Basic Healthcare Insurance List
Table 26: Traditional Chinese Medicine (TCM) Dermatosis Drugs on the National Basic Healthcare Insurance List
Table 27: New Dermatosis Drugs Approved in 2007

Table A: Hospital Coverage for the Monitoring and Tracking of Drug Prescription and Purchasing Data in China (Nan Fang Institute)
Figure 1: Market Sizes and Growth Rates of the Chinese Dermatosis Drug Market 2002-2007
Figure 2: Market Sizes and Sales Growths of Oral vs. External Use Dermatosis Drugs 2002-2007
Figure 3: Market Potential of Key Dermatosis Drugs
Figure 4: Market Shares of the Top 10 Dermatosis Drugs in China 2006
Figure 5: Market Shares of the Top 10 Dermatosis Drugs in China 2007

THE TOP 20 PHARMACEUTICAL COMPANIES IN THE CHINESE DERMATOSIS DRUG MARKET 2007
(At least >1.17% of the China Dermatosis Drug Market Shares)

Chongqing Huabang
Novartis
Xian-Janssen
Daiichi Seiyaku
Tianjin Pharmaceutical
Hong Kong Bright Future
Schering-Plough China
Tianjin SmithKline & French Laboratories Ltd.
Shandong Qilu
LEO Pharmaceutical
Laboratories Galderma S.A
Shanghai Likang
Shanghai Xinyi
Luitpold-Werk, Chemisch-Pharma, Fabrik
Bayer
Jiangsu Jichuan
Teijin Limited
Sichuan Dikang
Zhejiang Hangzhou Yishute
GSK

*** This is a partial list of companies, for a full listing request it ***

Other Ways To Purchase:

Call: 714-847-3540

Email Sales

* Single License allows for report sharing within one company location.
** Corporate License allows for report sharing within all company locations.

This report is listed in the following markets:
Aesthetics and Drug Delivery